UPDATE via Rik Deitsch: (EMAIL)
I just received information directly from Rik, via email correspondence. We talk from time to time, and he quickly responded today to my questions regarding filings, catalysts, anticipated news, GSA website, etc.
He informed me the annual 2017 filing is due March 30th and will be filed on time. He expects good things to be shared with us.
Rik has said the company did not announce the GSA-Advantage availability of their products because they knew that it would only be available on the GSA site for a week. Their partners in this, EuroAmerican, are finalizing their MAS application and expect to be permanently added to the GSA shortly. At that time, the company will then make an announcement with the details.
Rik says the company is truly undervalued, FACT. But, pointed out that while we recently traded in the $.006 range, the current trading is still 10-15 bags off of the 52 week lows on file. Rik has informed me that they will have more news, funding announcements, sales announcements and other info made available to shareholders very shorty, and stands behind this improving our market valuation.
I hope this info is as satisfying to everyone, as it was to me.
have a good day folks, we are on the brink of something very big here, ground floor. IMHO....
Nutra Pharma is a fantastic SEC reporting company with an even better CEO driving.
WIN-WIN-WIN
$NPHC
Shark
